Fast-tracking microtechniques to market
The TEMIS microtechniques science and technology park in eastern France is a magnet for emerging and innovative companies. One part of the park, the microtechniques competitiveness cluster, has worked with some 60 companies over the last three years.
"The Scout-M project enabled us to appreciate the importance of networking and reinforced our urge to diversify in the biomedical sector."
Denis Lyautey, Managing Director, Créatech
Founded in 2000 near Besançon, the park is an incubator for microtechniques and healthcare firms. It has a major economic influence on the region of Franche-Comté, as well as nationally and across Europe.
New technology cluster
Franche-Comté specialises in precision engineering and has several related higher education institutions. They increasingly focus on microtechniques – used to make tiny parts for consumer and industrial goods.
Covering 130 hectares, TEMIS (Technopole microtechnique et scientifique) is home to some 35 laboratories, both public and private, as well as transfer centres, research and educational institutions, and so on. Since the park’s launch, the companies and research laboratories on site have benefited for their projects from co-financing from the EU’s ERDF programme and the Franco-Swiss INTERREG III programme. Thirteen of these projects were awarded a total of €2.2 million from these European funds, out of a global budget of €4.6 million. The remaining funds were provided by the projects’ partners – the companies, laboratories and training organisations.
Among the organisations at TEMIS is the microtechniques competitiveness cluster (Pôle des microtechniques). It has contributed to several innovative collaborative projects, which bring together groups of researchers, technical or transfer centres, and businesses. One such project was SCOUT-M, which helped 10 firms (mainly SMEs) that design and make medical devices (ADS, Alliance, Createch, Deco-jura, Décolletage de la Garenne, Schrader, Plastigray, GEP, STS industrie, VP Plast) with market studies, training, client prospecting and manufacture. They were assisted for one year by four consultancies and supported by Johnson & Johnson.
Getting close to market
Of more than 80 commercial or R&D projects approved by the microtechniques competitiveness cluster, almost 30% are medical and health innovations. Three of the park’s first biomedical projects are being finalised. Among the SCOUT-M firms, two are seeking international quality certification and three now work together. Potential clients are also being followed up and partnerships established with Johnson & Johnson.
Some 400 jobs have been created at TEMIS over seven years. Almost 180 are in TEMIS Innovation, Maison des Microtechniques, created between 2002 and 2004.